NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundSelegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.ObjectiveScouting special and beneficial side effects of selegiline treatment.MethodTwo-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks' treatment.ResultsMass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.ConclusionSelegiline can successfully be used to stop/counterbalance certain symptoms of aging.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.